Viewing Study NCT01003418


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-05-25 @ 3:31 AM
Study NCT ID: NCT01003418
Status: TERMINATED
Last Update Posted: 2019-02-15
First Post: 2009-10-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 113629
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators